Adverse effects of nonsteroidal anti-inflammatory drugs on the colon

Current Gastroenterology Reports

Volumn 10, Issue 5, 2008, Pages 485-489

  Ballinger, Anne ^a  

^a EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PLACEBO; ROFECOXIB;

ABDOMINAL PAIN; ABSCESS; ANEMIA; ARTHRALGIA; BODY WEIGHT DISORDER; CASE CONTROL STUDY; CLINICAL TRIAL; COLITIS; COLLAGENOUS COLITIS; COLON DISEASE; COLON INJURY; COLON ISCHEMIA; COLON POLYP; COLON ULCER; CROHN DISEASE; DIARRHEA; DIGESTIVE SYSTEM INJURY; DIGESTIVE SYSTEM PERFORATION; DIGESTIVE SYSTEM ULCER; DIVERTICULOSIS; DRUG WITHDRAWAL; DUODENUM BLEEDING; ENTERITIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL OBSTRUCTION; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HUMAN; INCIDENCE; ISCHEMIC COLITIS; NONHUMAN; PERITONITIS; REVIEW; RHEUMATOID ARTHRITIS; SMALL INTESTINE HEMORRHAGE; ULCERATIVE COLITIS; UPPER GASTROINTESTINAL TRACT; VASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; COLON; DRUG EFFECT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS; COLON; COLONIC DISEASES; GASTROINTESTINAL HEMORRHAGE; HUMANS;

EID: 58149333593     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-008-0089-5     Document Type: Review

References (41)

1. Antonov KIM, Isacson DGL: Prescription and nonprescription analgesic use in Sweden. Ann Pharmacother 1998, 32: 485-494.
2. Blower AL, Brooks A, Fenn CG, et al.: Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Aliment Pharmacol Ther 1997, 11: 283-291.
3. Cryer B: NSAID-assoTiated deaths: the rise and fall of NSAID-associated GI mortality. Am J Gastroenterol 2005, 100: 1694-1695.
4. Silverstein FE, Graham DY, Senior JR, et al.: Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. Ann Intern Med 1995, 123: 241-249.
5. MacDonald TM, Morant SV, Robinson GC, et al.: Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: Cohort study. BMJ 1997, 315: 1333-1337.
6. Henry D, Lim L, Garcia Rodriguez L, et al.: Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: Results of a collaborative meta-analysis. BMJ 1996, 312: 1563-1566.
7. Garía Rodríguez LA, Cattaruzzi C, Troncon MG, Agostinis L: Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs. Arch Intern Med 1998, 158: 33-39.
8. Wilcox CM, Alexander LN, Cotsonis GA, Clark WS: Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding. Dig Dis Sci 1997, 42: 990-997.
9. Holt S, Rigoglioso V, Sidhu M, et al.: Nonsteroidal anti-inflammatory drugs and lower gastrointestinal bleeding. Dig Dis Sci 1993, 38: 1619-1623.
10. Kaplan RC, Heckbert SR, Psaty BM: Risk factors for hospitalized upper or lower gastrointestinal tract bleeding in treated hypertensives. Prev Med 2002, 34: 455-462.
11. Lanas A, Sekar MC, Hirschowitz BI: Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992, 103: 862-869.
12. Yocum D, Fleishman R, Dalgin P, et al.: Safety and efficacy of meloxicam in the treatment of osteoarthritis: A 12 week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators. Arch Intern Med 2000, 160: 2947-2954.
13. Rampton DS, Barton TP: Are prostaglandins cytoprotective in the human large intestine? The effect of indomethacin on rectal mucosal function and prostaglandin E2 release in vivo. Agents Actions 1984, 14: 715-718.
14. Slattery J, Warlow CP, Shorrock CJ, Langman MJ: Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin - analysis of gastrointestinal bleeding during the UK-TIA trial. Gut 1995, 37: 509-511.
15. Laine L, Connors LG, Reicin A, et al.: Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology 2003, 124: 288-292.
16. Langman MJ, Morgan L, Worrall A: Use of anti-inflammatory drugs by patients admitted with small or lower bowel perforations and haemorrhage. Br Med J (Clin Res Ed) 1985, 290: 347-349.
17. Lanas A, Serrano P, Bajador E, et al.: Evidence of aspirin use in both upper and lower gastrointestinal perforation. Gastroenterology 1997, 112: 683-689.
18. Wilson RG, Smith AN, Macintyre IM: Complications of diverticular disease and non-steroidal anti-inflammatory drugs: A prospective study. Br J Surg 1990, 77: 1103-1104.
19. Morris CR, Harvey IM, Stebbings WS, et al.: Anti-inflammatory drugs, analgesics and the risk of perforated colonic diverticular disease. Br J Surg 2003, 90: 1267-1272.
20. Goh H, Bourne R: Non-steroidal anti-inflammatory drugs and perforated diverticular disease: A case-control study. Ann R Coll Surg Engl 2002, 84: 93-96.
21. Campbell K, Steele RJ: Non-steroidal anti-inflammatory drugs and complicated diverticular disease: A case-control study. Br J Surg 1991, 78: 190-191.
22. Mpofu S, Mpofu CM, Hutchinson D, et al.: Steroids, nonsteroidal anti-inflammatory drugs and sigmoid diverticular abscess perforation in rheumatic conditions. Ann Rheum Dis 2004, 63: 588-590.
23. Yamada A, Sugimoto T, Kondo S, et al.: Assessment of the risk factors for colonic diverticular haemorrhage. Dis Colon Rectum 2008, 51: 116-120.
24. Tanner AR, Raghunath AS: Colonic inflammation and nonsteroidal anti-inflammatory drug administration. An assessment of the frequency of the problem. Digestion 1988, 41: 116-120.
25. Katsinelos P, Christodoulou K, Pilpilidis I, et al.: Colopathy associated with the systemic use of nonsteroidal anti-inflammatory medications. An underestimated entity. Hepatogastroenterology 2002, 49: 345-348.
26. Gibson GR, Whitacre EB, Ricotti CA: Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature. Arch Intern Med 1992, 152: 625-632.
27. Puspok A, Kiener HP, Oberhuber G: Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon. Dis Colon Rectum 2000, 43: 685-691.
28. Carratu R, Parisi P, Agozzino A: Segmental ischemic colitis associated with nonsteroidal antiinflammatory drugs. J Clin Gastroenterol 1993, 16: 31-34.
29. Goldstein NS, Cinenza AN: The histopathology of nonsteroidal anti-inflammatory drug-associated colitis. Am J Clin Pathol 1998, 110: 622-628.
30. Gleeson MH, Davis JM: Non-steroidal anti-inflammatory drugs, aspirin and newly diagnosed colitis: A case-control study. Aliment Pharmacol Ther 2003, 17: 817-825.
31. Houmani Z, Imbert A, Duchmann JC, et al.: Acute colitis following the beginning of celecoxib treatment [in French]. Gastroenterol Clin Biol 2005, 29: 1294-1295.
32. Rey P, Andriamanantena D, Carrère C, et al.: Ulcerating haemorrhagic colitis induced by celecoxib. Presse Med 2005, 34: 443-445.
33. Radaelli F, Feltri M, Meucci G, et al.: Ischemic colitis associated with rofecoxib. Dig Liver Dis 2005, 37: 372-376.
34. Fernández-Bañares F, Esteve M, Espinós JC, et al.: Drug consumption and the risk of microscopic colitis. Am J Gastroenterol 2007, 102: 324-330.
35. Al-Ghamdi MY, Malatjalian DA, Veldhuyzen van Zanten S: Causation: recurrent collagenous colitis following repeated use of NSAIDs. Can J Gastroenterol 2002, 16: 861-862.
36. Kakar S, Pardi DS, Burgart LJ: Colonic ulcers accompanying collagenous colitis: Implication of non-steroidal anti-inflammatory drugs. Am J Gastroenterol 2003, 98: 1834-1837.
37. Berg DJ, Zhang J, Weinstock JV, et al.: Rapid development of colitis in NSAID-treated IL-10 deficient mice. Gastroenterology 2002, 123: 1527-1542.
38. Shen B, Fazio VW, Remzi FH, et al.: Effect of withdrawal of nonsteroidal anti-inflammatory drug use on ileal pouch disorders. Dig Dis Sci 2007, 52: 3321-3328.
39. Takeuchi K, Smale S, Premchand P, et al.: Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2006, 4: 196-202.
40. Forrest K, Symmons D, Foster P: Systematic review: Is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease? Aliment Pharmacol Ther 2004, 20: 1035-1043.
41. Sandborn WJ, Stenson WF, Brynskov J, et al.: Safety of celecoxib in patients with ulcerative colitis in remission: A randomized, placebo-controlled, pilot study. Clin Gastroenterol Hepatol 2006, 4: 203-211.